PROVIDENCE, RI, UNITED STATES, March 17, 2026 — Lenoss Medical, a biomedical growth stage company offering the first and only biological solution to the spinal vertebral augmentation market, today announced the successful closing of a $6 million growth bridge financing round, reinforcing strong investor confidence in the company’s commercial progress and long-term growth strategy for its OsteoPearl® platform solution.